SGLT2 inhibitor sick-day advice — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Seek prescriber advice about withholding empagliflozin during fasting and illness risk
SGLT2 inhibitors increase the risk of euglycaemic diabetic ketoacidosis during acute illness, prolonged fasting, dehydration, and peri-procedural periods. The patient should receive clear sick-day or procedural advice from the diabetes team or prescriber, including when to withhold and restart. Extra dosing would increase risk rather than prevent complications.
Reference: BNF; MHRA; NICE CKS